Carboplatin is a platinum-based chemotherapy drug used mainly to treat various cancers, including ovarian, lung, and head and neck cancers. It is a second-generation analog of cisplatin with a cyclobutane dicarboxylic acid ligand, offering reduced nephrotoxicity and gastrointestinal side effects. Carboplatin works by forming DNA cross-links, thereby inhibiting DNA replication and leading to cancer cell death. It is grouped under the following drug class(es): Alkylating agents, Antineoplastic agents, Cytotoxics and Platinum compounds. Its therapeutic use is listed as anti-cancer agents and antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Paraplatin, Ercar, Blastocarb and Ribocarbo. Its PubChem CID is 10339178.
Carboplatin
| CAS No | 41575-94-4 |
|---|---|
| Molecular Formula | C6H12N2O4Pt |
| Molecular Weight | 371.25 g/mol |
| Synonyms | azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Carboplatin is a platinum-based chemotherapy drug used mainly to treat various cancers, including ovarian, lung, and head and neck cancers. It is a second-generation analog of cisplatin with a cyclobutane dicarboxylic acid ligand, offering reduced nephrotoxicity and gastrointestinal side effects.
The listed CAS number is 41575-94-4.
The listed molecular formula is C6H12N2O4Pt.
The listed molecular weight is 371.25 g/mol.
azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+).
The source lists Paraplatin, Ercar, Blastocarb and Ribocarbo.